From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From QAAPAPLE 1 to QAAPAPLE 2: how do we move from one algorithm to another one with Long Acting Antipsychotics (LAIs)
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-09-23
DOI
10.1080/14737175.2020.1826930
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
- (2020) Hye Ok Kim et al. Annals of General Psychiatry
- Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review
- (2019) Kamyar Keramatian et al. CNS DRUGS
- Long‐acting antipsychotic medication as first‐line treatment of first‐episode psychosis with comorbid substance use disorder
- (2019) Amal Abdel‐Baki et al. Early Intervention in Psychiatry
- Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission
- (2019) Philip Gorwood et al. PSYCHIATRY RESEARCH
- Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies
- (2018) Chris Cameron et al. CURRENT MEDICAL RESEARCH AND OPINION
- Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
- (2018) Markku Lähteenvuo et al. JAMA Psychiatry
- Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia
- (2017) Chi-Un Pae et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies
- (2017) Taishiro Kishimoto et al. SCHIZOPHRENIA BULLETIN
- Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up
- (2017) Heidi Taipale et al. SCHIZOPHRENIA BULLETIN
- Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies
- (2017) Giovanni Ostuzzi et al. SCHIZOPHRENIA RESEARCH
- Les antipsychotiques injectables à action prolongée: Avis d'experts de l'Association des médecins psychiatres du Québec
- (2017) Emmanuel Stip et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Long-Acting Injectable Antipsychotics for Prevention of Relapse in Bipolar Disorder: A Systematic Review and Meta-Analyses of Randomized Controlled Trials
- (2016) Taro Kishi et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics
- (2016) Fuminari Misawa et al. SCHIZOPHRENIA RESEARCH
- Comparative effectiveness of long-acting antipsychotics: issues and challenges from a pragmatic randomised study
- (2015) G. Ostuzzi et al. Epidemiology and Psychiatric Sciences
- Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia
- (2015) Kenneth L. Subotnik et al. JAMA Psychiatry
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in Schizophrenia
- (2013) Noam Y. Kirson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Efficacy and safety of second-generation long-acting injections in schizophrenia
- (2012) Paolo Fusar-Poli et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
- (2011) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trials
- (2011) Claudia Leucht et al. SCHIZOPHRENIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now